Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation

Communications Biology(2021)10.1038/s42003-021-02440-3Source: DataRank Database

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation is a research paper published in Communications Biology (2021). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (14)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Fahmin Basher ORCID,Zhe Ji ORCID,Lei Huang ORCID,Si Qin ORCID,Derek A. Wainwright ORCID

Live enrichment

PubMed:19910364

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1R01CA208246

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1R01CA204021

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1R01CA212409

National Institutes of Health

Grant: 5R01CA208246-04

NKG2D superagonist co-stimulation to enhance adaptive immunotherapy of cancer

National Institutes of Health

Grant: 5R01CA212409-03

Tumor immune and glycan biomarkers for progressive prostate cancer

National Institutes of Health

Grant: 5R01CA204021-07

Target MIC shedding to revive anti-tumor immunity

goldLicense: cc-by

publisherhttps://www.nature.com/articles/s42003-021-02440-3.pdf

publisherhttps://www.nature.com/articles/s42003-021-02440-3

repositoryhttps://doaj.org/article/0aee9ce5734644cbbebb591f8c4256a4

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8298432

https://doi.org/10.1038/s42003-021-02440-3

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

InflammationQH301-705.5Cellular ReprogrammingLigandsArticleKiller Cells, NaturalPhenotypeNK Cell Lectin-Like Receptor Subfamily KCell Line, TumorHumansBiology (General)

Sustainable Development Goals

SDG 3: 3. Good health